Stratec SE (ETR:SBS – Get Free Report) shares rose 0.4% on Friday . The stock traded as high as €24.80 and last traded at €24.60. 2,128 shares changed hands during mid-day trading, a decline of 66% from the average session volume of 6,253 shares. The stock had previously closed at €24.50.
Stratec Trading Down 1.8%
The company has a market cap of $290.13 million, a P/E ratio of 28.98, a P/E/G ratio of 10.43 and a beta of 0.81. The company has a quick ratio of 1.65, a current ratio of 4.23 and a debt-to-equity ratio of 48.53. The business has a 50-day moving average price of €20.41 and a two-hundred day moving average price of €19.04.
Stratec Company Profile
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Read More
- Five stocks we like better than Stratec
- Zscaler’s Strong Quarter Still Left Investors Waiting on 1 Key Signal
- Is Duolingo the Next Netflix-Style Comeback Story?
- GitLab’s AI Tools Are Starting to Turn Developer Demand Into Real Revenue
- GTA VI’s Console Problem Isn’t Take-Two’s Problem
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
